![Logo der Firma ObsEva](http://cdn.lifepr.de/f/fabda4dd4914c98c/logos/92502/500_500.gif)
ObsEva Presents Pharmacology Data Showing that OBE002, the First Orally Active Prostaglandin F2alpha Antagonist, is devoid of the side effects associated with NSAID treatment of Preterm Labor
ObsEva, a Swiss biopharmaceutical company developing a novel generation of drugs addressing serious conditions compromis…